Fisetin Supplementation for Healthy Aging

Abroad (travel likely)Recruiting

Conditions

Healthy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Clinical Research, Copenhagen University Hospital Amager & Hvidovre, Hvidovre, Denmark
Contact: Study coordinator (Juliette Tavenier) · juliette.tavenier@regionh.dk · +4538620958

Study leads

Juliette Tavenier
Study Chair
Copenhagen University Hospital, Amager and Hvidovre
Line Jee Hartmann Rasmussen
Study Chair
Copenhagen University Hospital, Amager and Hvidovre
Morten B Houlind
Study Chair
Copenhagen University Hospital, Amager and Hvidovre
Magnus Berglind
Study Chair
Copenhagen University Hospital, Amager and Hvidovre
Line Fleischer Hach
Study Chair
Copenhagen University Hospital, Amager and Hvidovre

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

Healthy Adult Participants · Diabetic Kidney Disease

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia

A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Auckland, New Zealand

A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults

Healthy Participants · Healthy Adult Females · Healthy Adult Male

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

Healthy Volunteers

Abroad (travel likely)RecruitingPHASE1

Grayslake, United States